Overexpression of N-cadherin is correlated with metastasis and worse survival in colorectal cancer patients

Chinese Science Bulletin

Volumn 58, Issue 28-29, 2013, Pages 3529-3534

  Zhuo, HongQing ^a   Jiang, KeWei ^a   Dong, LingYi ^a   Zhu, Yi ^a   Lü, Liang ^a   Lü, You ^a   Zhang, YanBin ^a   Zhang, Hui ^a   Ye, YingJiang ^a   Wang, Shan ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

colorectal neoplasms; immunohistochemistry; N cadherin; prognosis

Indexed keywords

EID: 84885584467     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-013-5813-3     Document Type: Article

References (33)

1. Siegel R, Ward E, Brawley O, et al. Cancer statastics, 2011. CA Cancer J Clin, 2011, 61: 212-236.
2. Zhao P, Dai M, Chen W, et al. Cancer trends in China. Jpn J Clin Oncol, 2010, 40: 281-285.
3. Qin L, Xiao Y, Chen Y. Strategy against micrometastasis of epithelial cancer: Detection and elimination. Chin Sci Bull, 2002, 47: 1415-1421.
4. Nollet F, Kools P, van Roy F. Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol, 2000, 299: 551-572.
5. Hatta K, Okada T S, Takeichi M. A monoclonal antibody disrupting calcium-dependent cell-cell adhesion of brain tissues: Possible role of its target antigen in animal pattern formation. Proc Natl Acad Sci USA, 1985, 82: 2789-2793.
6. Hazan R B, Phillips G R, Qiao R F, et al. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol, 2000, 148: 779-790.
7. Hulit J, Suyama K, Chung S, et al. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Res, 2007, 67: 3106-3116.
8. Su Y, Li J, Witkiewicz A K, et al. N-cadherin haploinsufficiency increases survival in a mouse model of pancreatic cancer. Oncogene, 2012, 31: 4484-4489.
9. Jennbacken K, Tesan T, Wang W, et al. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer. Endocr Relat Cancer, 2010, 17: 469-479.
10. Maeda M, Johnson K R, Wheelock M J. Cadherin switching: Essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci, 2005, 118: 873-887.
11. Kevans D, Wang L, Sheahan K, et al. Epithelial-mesenchymal Transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status. Int J Surg Pathol, 2011, 19: 751-760.
12. Dong L, Jiang K, Zhang Y, et al. BAP31 is frequently overexpressed in patients with primary colorectal cancer and correlates with better prognosis. Chin Sci Bull, 2011, 56: 2444-2449.
13. Zhang Y, Ye Y, Shen D, et al. Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis. Cancer Sci, 2010, 101: 523-529.
14. Hazan R B, Kang L, Whooley B P, et al. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun, 1997, 4: 399-411.
15. Derycke L D, Bracke M E. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Dev Biol, 2004, 48: 463-476.
16. Mikesh L M, Kumar M, Erdag G, et al. Evaluation of molecular markers of mesenchymal phenotype in melanoma. Melanoma Res, 2010, 20: 485-495.
17. Ma Y, Wang K, Li L, et al. Expression of Twist, E-cadherin and N-cadherin in breast carcinoma and their clinical significance (in Chinese). Zhonghua Bing Li Xue Za Zhi, 2010, 39: 5-9.
18. Gravdal K, Halvorsen O J, Haukaas S A, et al. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res, 2007, 13: 7003-7011.
19. Nakagawa M, Bando Y, Nagao T, et al. Expression of p53, Ki-67, E-cadherin, N-cadherin and TOP2A in triple-negative breast cancer. Anticancer Res, 2011, 31: 2389-2393.
20. Nguyen P T, Kudo Y, Yoshida M, et al. N-cadherin expression is correlated with metastasis of spindle cell carcinoma of head and neck region. J Oral Pathol Med, 2011, 40: 77-82.
21. Nguyen P T, Kudo Y, Yoshida M, et al. N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelial-mesenchymal transition. Histol Histopathol, 2011, 26: 147-156.
22. Araki K, Shimura T, Suzuki H, et al. E/N-cadherin switch mediates cancer progression via TGF-beta-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. Br J Cancer, 2011, 105: 1885-1893.
23. Chu Y S, Thomas W A, Eder O, et al. Force measurements in E-cadherin-mediated cell doublets reveal rapid adhesion strengthened by actin cytoskeleton remodeling through Rac and Cdc42. J Cell Biol, 2004, 167: 1183-1194.
24. Nalla A K, Estes N, Patel J, et al. N-cadherin mediates angiogenesis by regulating monocyte chemoattractant protein-1 expression via PI3K/Akt signaling in prostate cancer cells. Exp Cell Res, 2011, 317: 2512-2521.
25. Sandig M, Voura E B, Kalnins V I, et al. Role of cadherins in the transendothelial migration of melanoma cells in culture. Cell Motil Cytoskeleton, 1997, 38: 351-364.
26. Zhan D, Wei S, Liu C, et al. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma. J Gastroenterol Hepatol, 2011, 27: 173-180.
27. Ponnusamy M P, Lakshmanan I, Jain M, et al. MUC4 mucin-induced epithelial to mesenchymal transition: A novel mechanism for metastasis of human ovarian cancer cells. Oncogene, 2010, 29: 5741-5754.
28. Yee D S, Tang Y, Li X, et al. The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition. Mol Cancer, 2010, 9: 162.
29. Tang D, Dong S, Ma N, et al. Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. Hepatology, 2010, 51: 1255-1263.
30. Liu L, Zhu X, Wang W, et al. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. Clin Cancer Res, 2010, 16: 2740-2750.
31. Yang J, Zhang X, Liu J, et al. Expression and significance of N-cadherin and beta-catenin protein in osteosarcoma (in Chinese). Zhonghua Zhong Liu Za Zhi, 2010, 32: 586-589.
32. Muramaki M, Miyake H, Terakawa T, et al. Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy. Urology, 2011, 78: 1443 e7-1443 e12.
33. Armstrong A J, Marengo M S, Oltean S, et al. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res, 2011, 9: 997-1007.